FDMT vs GEN · rev $37.0K vs P/E 17, rev $5.00B
4D Molecular Therapeutics Inc (FDMT) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
FDMT currently screens at market cap $518.1M. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the FDMT and GEN stock pages for the full models.
Not investment advice.